April 6, 2016 / 2:52 PM / 2 years ago

BRIEF-Allergan CEO says considering share buyback

April 6 (Reuters) -

* Allergan CEO Saunders says committed to double-digit revenue growth in branded products

* Allergan CEO says everything is on the table including share buybacks and returning capital to shareholders

* Allergan CEO says Valeant’s B&L is different enough than Allergan‘s, but unclear if it is a growth business that would be good M&A target

* Allergan CEO also says that Bausch & Lomb is not for sale (Reporting By Caroline Humer)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below